Marlowe (MRL) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
4 Mar, 2026Executive summary
Revenue from continuing operations grew 4% year-over-year to £304.5m, driven by organic growth and acquisitions.
Adjusted EBITDA from continuing operations rose 4% to £32.8m, with margin stable at 10.8%.
Statutory profit before tax improved to £2.8m from a loss of £9.2m, reflecting lower adjusting items.
Group revenue was £373.0m, including contributions from divestments and demergers.
Financial highlights
Adjusted profit before tax increased 37% year-over-year to £18.2m.
Adjusted EPS rose 47% to 15.3p; statutory EPS improved to 5.0p from (6.0)p.
Cash generated from operations before adjusting items was £48.7m, with 105% cash conversion.
Closing net cash position (excluding leases) was £22.2m, a swing from net debt of £176.6m, aided by divestment proceeds.
Outlook and guidance
Market remains supported by long-term regulatory and non-discretionary demand drivers.
Significant M&A opportunities exist in fragmented TIC markets, with a £7.8bn addressable market.
Mitie’s recommended offer for the group implies a total enterprise value of £366m and a 39% premium to the 3-month average share price.
Latest events from Marlowe
- GRC divestment and robust cash flow set stage for organic growth and margin recovery.MRL
H2 20244 Mar 2026 - 4% revenue growth, £430m divestment, and £200m capital return drive TIC focus.MRL
H1 20254 Mar 2026 - Strong FY25 results, strategic divestment, and SludgeTek acquisition boost Marlowe's growth.MRL
Trading Update6 Jun 2025